Abstract:Up to 15% of patients with essential hypertension have inappropriate regulation of aldosterone; although only a minority have distinct adrenal tumors, recent evidence shows that mineralocorticoid receptor activation contributes to the age-related blood pressure rise and illustrates the importance of aldosterone in determining cardiovascular risk. Aldosterone also has a major role in progression and outcome of ischemic heart disease. These data highlight the need to understand better the regulation of aldosterone synthesis and its action. Aldosterone effects are mediated mainly through classical nuclear receptors that alter gene transcription. In classic epithelial target tissues, signaling mechanisms are relatively well defined. However, aldosterone has major effects in nonepithelial tissues that include increased synthesis of proinflammatory molecules and reactive oxygen species; it remains unclear how these effects are controlled and how receptor specificity is maintained. Variation in aldosterone production reflects interaction of genetic and environmental factors. Although the environmental factors are well understood, the genetic control of aldosterone synthesis is still the subject of debate. Aldosterone synthase (encoded by the CYP11B2 gene) controls conversion of deoxycorticosterone to aldosterone. Polymorphic variation in CYP11B2 is associated with increased risk of hypertension, but the molecular mechanism that accounts for this is not known. Altered 11beta-hydroxylase efficiency (conversion of deoxycortisol to cortisol) as a consequence of variation in the neighboring gene (CYP11B1) may be important in contributing to altered control of aldosterone synthesis, so that the risk of hypertension may reflect a digenic effect, a concept that is discussed further. There is evidence that a long-term increase in aldosterone production from early life is determined by an interaction of genetic and environmental factors, leading to the eventual phenotypes of aldosterone-associated hypertension and cardiovascular damage in middle age and beyond. The importance of aldosterone has generated interest in its therapeutic modulation. Disadvantages associated with spironolactone (altered libido, gynecomastia) have led to a search for alternative mineralocorticoid receptor antagonists. Of these, eplerenone has been shown to reduce cardiovascular risk after myocardial infarction. The benefits and disadvantages of this therapeutic approach are discussed.

The Role of Progesterone Metabolism and Androgen Synthesis in Renal Blood Pressure Regulation

Progressive 11β-Hydroxysteroid Dehydrogenase Type 2 Insufficiency as Kidney Function Declines

A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function

Different effects of progesterone and estradiol on chimeric and wild type aldosterone synthase in vitro

Interactions Between 11 Beta-Hydroxysteroid Dehydrogenase And Cox-2 In Kidney

11beta-hydroxysteroid dehydrogenase type 2 activity in hypothalamic paraventricular nucleus modulates sympathetic excitation.

Interactions between 11beta-hydroxysteroid dehydrogenase and COX-2 in kidney

Mineralocorticoid Receptor and Aldosterone: Interaction Between NR3C2 Genetic Variants, Sex, and Age in a Mixed Cohort

Prostaglandins and Renal Function

Corticosteroid Dynamics in the Nonpregnant, Pregnant, and Postpartum Spontaneously Hypertensive Rat.

Aldosterone and mineralocorticoid receptors in regulation of the cardiovascular system and pathological remodelling of the heart and arteries

Aldosterone synthase gene variation and adrenocortical response to sodium status, angiotensin II and ACTH in normal male subjects

Evaluating the role of aldosterone synthesis on adrenal cell fate

Impaired 11β-hydroxysteroid dehydrogenase type 2 activity in kidney disease disrupts 11-oxygenated androgen biosynthesis

Regulation of 11Β-Hydroxysteroid Dehydrogenase Type 2 by Progesterone, Estrogen, and the Cyclic Adenosine 5′-Monophosphate Pathway in Cultured Human Placental and Chorionic Trophoblasts1

Other physiological considerations of protective mechanisms of mineralocorticoid action

Placental 11 beta-hydroxysteroid dehydrogenase and the programming of hypertension

Progesterone: An enigmatic ligand for the mineralocorticoid receptor

Regulation of 20α-Hydroxysteroid Dehydrogenase Expression in Term Pregnant Human Myometrium Ex Vivo

Adverse Effects of Aldosterone: Beyond Blood Pressure

Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system.